Respect des Standards consolidés dans des rapports d’essais (CONSORT) lignes directrices pour la déclaration des résultats de sécurité dans les essais des cannabinoïdes pour la douleur chronique : protocole pour un examen systématique.

Published by Michael on

Related Posts

Medical

Inhaled Cannabis Suppresses Chemotherapy-Induced Neuropathic Nociception by Decoupling the Raphe Nucleus: A Functional Imaging Study in Rats

Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Dec 13:S2451-9022(20)30370-0. doi: 10.1016/j.bpsc.2020.11.015. Online ahead of print. ABSTRACT BACKGROUND: Efficacy of inhaled cannabis for treating pain is controversial. Effective treatment for chemotherapy-induced neuropathy represents an unmet medical need. Read more…

Medical

The association between cannabis use and outcome in pharmacological treatment for opioid use disorder

Harm Reduct J. 2021 Feb 23;18(1):24. doi: 10.1186/s12954-021-00468-6. ABSTRACT BACKGROUND: With the ongoing opioid crisis and policy changes regarding legalization of cannabis occurring around the world, it is necessary to consider cannabis use in the Read more…

Medical

Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans

CMAJ Open. 2021 Feb 23;9(1):E115-E124. doi: 10.9778/cmajo.20200021. Print 2021 Jan-Mar. ABSTRACT BACKGROUND: Injectable opioid agonist treatment (iOAT) is an emerging evidence-based option in the continuum of care for opioid use disorder in parts of Canada. Read more…

error: Content is protected !!